| __timestamp | Bausch Health Companies Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 8263500000 | 1288519000 |
| Thursday, January 1, 2015 | 10498800000 | 1465761000 |
| Friday, January 1, 2016 | 9674000000 | 1598800000 |
| Sunday, January 1, 2017 | 8724000000 | 1725300000 |
| Monday, January 1, 2018 | 8380000000 | 1627800000 |
| Tuesday, January 1, 2019 | 8601000000 | 1448800000 |
| Wednesday, January 1, 2020 | 8027000000 | 1483300000 |
| Friday, January 1, 2021 | 8434000000 | 1685500000 |
| Saturday, January 1, 2022 | 8124000000 | 1936300000 |
| Sunday, January 1, 2023 | 8757000000 | 2327500000 |
Data in motion
In the competitive landscape of the pharmaceutical industry, revenue growth is a key indicator of success. Over the past decade, Bausch Health Companies Inc. has consistently outpaced United Therapeutics Corporation in terms of annual revenue. From 2014 to 2023, Bausch Health's revenue averaged approximately $8.75 billion annually, peaking in 2015 with a 20% increase from the previous year. In contrast, United Therapeutics, while showing steady growth, averaged around $1.66 billion annually, with its highest revenue in 2023, marking an 80% increase since 2014.
Despite the disparity in revenue, United Therapeutics has demonstrated a remarkable growth trajectory, nearly doubling its revenue over the period. This trend highlights the company's potential to close the gap with its larger competitor. As the industry evolves, both companies continue to innovate and expand, promising exciting developments in the years to come.
Breaking Down Revenue Trends: GSK plc vs Bausch Health Companies Inc.
Revenue Showdown: United Therapeutics Corporation vs Genmab A/S
Who Generates More Revenue? United Therapeutics Corporation or Exelixis, Inc.
Comparing Revenue Performance: United Therapeutics Corporation or Lantheus Holdings, Inc.?
United Therapeutics Corporation vs Cytokinetics, Incorporated: Examining Key Revenue Metrics
Cost of Revenue: Key Insights for United Therapeutics Corporation and Bausch Health Companies Inc.
United Therapeutics Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Breaking Down Revenue Trends: United Therapeutics Corporation vs Celldex Therapeutics, Inc.
MorphoSys AG and Bausch Health Companies Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bausch Health Companies Inc. vs Merus N.V.
Comparing Revenue Performance: Bausch Health Companies Inc. or Mesoblast Limited?
Comparing Revenue Performance: Bausch Health Companies Inc. or Dynavax Technologies Corporation?